About The Webinar
Seizures are aetiologically categorised as idiopathic, symptomatic or reactive. Idiopathic epilepsy is the most common cause in dogs and cats. The main aims of antiepileptic treatment are to reduce the frequency and severity of seizures while minimising potential side effects and optimising the owner’s and dog’s quality of life. Most epileptic dogs are treated pharmacologically successfully for life with phenobarbitone. However, about 20 – 30% of treated dogs are reported to either be poorly responsive to phenobarbitone and/or suffer unacceptable side effects and toxicity. In patients with apparent refractory epilepsy, it is essential to search for errors in diagnosis or management that may be responsible for treatment failure. This presentation proposes a step-wise approach to suspected refractory epileptic patients.